We are live on
!
Find out more
MAP
Moody Aldrich Partners Portfolio holdings
AUM
$557M
1-Year Est. Return
122.79%
This Fund
S&P 500
This Quarter
Est. Return
+6.22%
1 Year Est. Return
+122.79%
3 Year Est. Return
+335.86%
5 Year Est. Return
+437.05%
10 Year Est. Return
+2,951.39%
AUM
$123M
AUM Growth
+$26.2M
(+27%)
Cap. Flow
+$22.8M
Cap. Flow
% of AUM
18.51%
Top 10 Holdings %
Top 10 Hldgs %
21.99%
Holding
103
New
12
Increased
66
Reduced
11
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Columbia Banking Systems
COLB
|
+$2.38M |
| 2 |
CSFL
CenterState Bank Corporation Common Stock
CSFL
|
+$1.95M |
| 3 |
AAMI
Acadian Asset Management
AAMI
|
+$1.47M |
| 4 |
ECOL
US Ecology, Inc.
ECOL
|
+$1.25M |
| 5 |
NorthWestern Energy
NWE
|
+$1.23M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CBM
Cambrex Corporation
CBM
|
+$1.97M |
| 2 |
Hexcel
HXL
|
+$1.49M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$1.33M |
| 4 |
Western Alliance Bancorporation
WAL
|
+$1.13M |
| 5 |
Bankunited
BKU
|
+$965K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.33% |
| 2 | Financials | 17.48% |
| 3 | Consumer Discretionary | 13.85% |
| 4 | Industrials | 12.39% |
| 5 | Real Estate | 7.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ESPR
76
DELISTED
Esperion Therapeutics
ESPR
| $746K | 0.6% |
11,327
+2,347
| +26% | +$126K |
|
77
Forum Energy Technologies
FET
$835M
| $666K | 0.54% |
2,142
+407
| +23% | +$116K |
|
|
ALEX
78
DELISTED
Alexander & Baldwin
ALEX
| $590K | 0.48% |
21,283
+4,441
| +26% | +$173K |
|
|
PDCE
79
DELISTED
PDC Energy, Inc.
PDCE
| $569K | 0.46% |
11,045
+2,304
| +26% | +$109K |
|
|
JUNO
80
DELISTED
Juno Therapeutics, Inc.
JUNO
| $478K | 0.39% |
10,461
-1,565
| -13% | -$78.1K |
|
81
Lumentum
LITE
$69.3B
| $476K | 0.39% |
+9,733
| New | +$543K |
|
|
OCLR
82
DELISTED
Oclaro Inc.
OCLR
| $367K | 0.3% |
54,385
-20,164
| -27% | -$149K |
|
|
SIVB
83
DELISTED
SVB Financial Group
SIVB
| $296K | 0.24% |
1,265
-2
| -0.2% | -$426 |
|
84
SEI Investments
SEIC
$12.6B
| $252K | 0.2% |
3,505
-5
| -0.1% | -$335 |
|
85
Jack Henry & Associates
JKHY
$11.1B
| $245K | 0.2% |
2,094
-11
| -0.5% | -$1.23K |
|
86
A.O. Smith
AOS
$8.7B
| $220K | 0.18% |
3,586
-8
| -0.2% | -$485 |
|
87
Sun Communities
SUI
$14.7B
| $212K | 0.17% |
+2,286
| New | +$210K |
|
|
88
Neurocrine Biosciences
NBIX
$16.6B
| $210K | 0.17% |
2,702
-19,554
| -88% | -$1.33M |
|
89
Broadridge
BR
$19B
| $204K | 0.17% |
+2,249
| New | +$196K |
|
|
90
Bankunited
BKU
$3.36B
| – | – |
-27,136
| Closed | -$965K |
|
91
Cirrus Logic
CRUS
$6.26B
| – | – |
-6,367
| Closed | -$339K |
|
|
EXAS
92
DELISTED
Exact Sciences
EXAS
| – | – |
-10,010
| Closed | -$472K |
|
93
Highwoods Properties
HIW
$3.47B
| – | – |
-13,912
| Closed | -$725K |
|
|
94
Hexcel
HXL
$7.82B
| – | – |
-26,021
| Closed | -$1.49M |
|
95
MKS Inc
MKSI
$20.6B
| – | – |
-6,862
| Closed | -$648K |
|
96
Molina Healthcare
MOH
$10.3B
| – | – |
-5,973
| Closed | -$411K |
|
97
Puma Biotechnology
PBYI
$454M
| – | – |
-5,292
| Closed | -$634K |
|
|
98
Western Alliance Bancorporation
WAL
$8.87B
| – | – |
-21,208
| Closed | -$1.13M |
|
|
COHR
99
DELISTED
Coherent Inc
COHR
| – | – |
-1,994
| Closed | -$469K |
|
|
CSOD
100
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| – | – |
-9,771
| Closed | -$397K |
|
Similar funds
CAM
QL
TCM
CFP
TC
DIM
NCA
CA
Moody Aldrich Partners's Q4 2017 Portfolio in Review
As of Q4 2017, Moody Aldrich Partners held 103 positions worth $123M, up 27% from $97.2M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Moody Aldrich Partners deployed $22.8M of net new capital in Q4 2017, opening 12 new positions and adding to 66 existing holdings. Its largest new stake was Columbia Banking Systems: 54,594 shares worth $2.37M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Neurocrine Biosciences, an estimated $1.33M trimmed.
- Moody Aldrich Partners's largest Q4 2017 buy was Columbia Banking Systems: 54,594 shares worth $2.37M.
- Moody Aldrich Partners added most to Heartland Express in Q4 2017, an estimated $923K increase.
- Moody Aldrich Partners's biggest Q4 2017 reduction was Neurocrine Biosciences, cutting an estimated $1.33M.
- Moody Aldrich Partners fully exited Cambrex Corporation in Q4 2017, selling an estimated $1.97M.
- Moody Aldrich Partners's ten largest holdings make up 22% of its $123M portfolio in Q4 2017.
- Moody Aldrich Partners opened 12 new positions and closed 14 in Q4 2017.
- Moody Aldrich Partners's portfolio value rose 27% quarter-over-quarter to $123M.
Based on Moody Aldrich Partners's 13F filing for Q4 2017, filed 31 Jan 2018.